The Mycobacterium smegmatis bd-II terminal oxidase employs a carboxylate shift mechanism.

Kovalova T, Janczak M, Gamiz-Hernandez AP, Lundin D, Sharma S, Vilhjálmsdóttir J, Sjöstrand D, Kaila VRI, Högbom M, Ädelroth P

Proc. Natl. Acad. Sci. U.S.A. 123 (11) e2515348123 [2026-03-17; online 2026-03-10]

Cytochrome bd is a terminal oxidase expressed under low oxygen conditions and central for the survival of many pathogens. Here, we characterize the cyt bd-II from , a member of a hitherto uncharacterized evolutionary group (qOR-2) of Mycobacterium smegmatisbd oxidases, by combining biochemical studies with cryo-electron microscopy (cryo-EM), and multiscale simulations. Overexpressing the appCB operon in its native host led to production of a highly active bd-II (kobs = 30 e- s-1) that together with a high-resolution (2.8 Å) cryo-EM structure and multiscale simulations reveal unique proton pathways and oxygen channels responsible for its function. We propose that a pH-dependent molecular switch, involving coordination changes of heme d and surrounding bulky residues regulate substrate access into the active site. Taken together, our findings provide detailed mechanistic insight of qOR-2 type bd oxidases, and a basis for understanding the evolution of the superfamily.

Cryo-EM [Service]

PubMed 41805574

DOI 10.1073/pnas.2515348123

Crossref 10.1073/pnas.2515348123

pmc: PMC12994193


Publications 9.5.2